Gene editing startup Metagenomi finally sets IPO range, as preclinical biotech eyes $87M - Endpoints News
endpts.comSubmitted by endpointsnews6292 in business
Gene editing company Metagenomi has set a price range for its proposed initial public offering, marking a key step for preclinical biotechs after weeks of anticipation on whether the California startup would follow through with a listing. Metagenomi expects n…